Ardent Health (NYSE:ARDT) Now Covered by BMO Capital Markets

BMO Capital Markets began coverage on shares of Ardent Health (NYSE:ARDT) in a research report issued on Tuesday, Marketbeat reports. The firm set a “hold” rating on the stock.

ARDT has been the subject of a number of other research reports. Leerink Partners reaffirmed an “outperform” rating and issued a $14.00 target price on shares of Ardent Health in a report on Friday, September 18th. Weiss Ratings downgraded shares of Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Tuesday, August 11th. Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a report on Monday, September 7th. Royal Bank Of Canada upped their price target on shares of Ardent Health from $12.00 to $13.00 and gave the company an “outperform” rating in a research report on Monday, August 10th. Finally, The Goldman Sachs Group reaffirmed a “neutral” rating and set a $13.00 price target on shares of Ardent Health in a research note on Thursday, August 6th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $12.79.

Ardent Health Price Performance

Ardent Health stock traded down $0.14 during midday trading on Tuesday, reaching $10.50. The company’s stock had a trading volume of 470,669 shares, compared to its average volume of 413,067. Ardent Health has a 52 week low of $7.71 and a 52 week high of $15.48. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61. The business has a 50-day moving average price of $10.86 and a 200-day moving average price of $9.94. The stock has a market cap of $1.48 billion, a PE ratio of 8.83, a price-to-earnings-growth ratio of 3.10 and a beta of 0.71.

Ardent Health (NYSE:ARDT) last posted its earnings results on Tuesday, August 4th. The company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). Ardent Health had a return on equity of 10.35% and a net margin of 1.22%.The company had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. On average, sell-side analysts predict that Ardent Health will post 0.96 EPS for the current year.

Hedge Funds Weigh In On Ardent Health

A number of hedge funds have recently made changes to their positions in ARDT. Wedge Capital Management L L P NC lifted its stake in shares of Ardent Health by 212.3% in the second quarter. Wedge Capital Management L L P NC now owns 327,242 shares of the company’s stock worth $3,220,000 after acquiring an additional 222,447 shares during the period. Hsbc Holdings PLC acquired a new stake in Ardent Health during the 2nd quarter valued at approximately $543,000. Ieq Capital LLC bought a new position in Ardent Health during the 2nd quarter worth approximately $907,000. Bank of New York Mellon Corp bought a new position in Ardent Health during the 2nd quarter worth approximately $2,377,000. Finally, LSV Asset Management bought a new position in Ardent Health during the 4th quarter worth approximately $963,000.

Ardent Health Company Profile

Ardent Health is a U.S. healthcare provider that owns and operates hospitals, outpatient facilities and other healthcare services. The company delivers a broad range of medical care, including emergency services, inpatient and outpatient treatment, primary care, specialty care, surgical services, behavioral health and urgent care.

Headquartered in Nashville, Tennessee, Ardent serves communities through a network of hospitals and healthcare sites in several states, including Texas, Oklahoma, New Mexico and Kansas.